The central challenge the researchers tackled is one of scale. Traditional phage genetics proceeds gene by gene: a researcher deletes or mutates a candidate gene and observes the consequence. That approach is slow, biased toward genes with predictable functions, and poorly suited to the many phage genes of unknown purpose that dominate most viral genomes. Transposon-insertion sequencing, or Tn-seq, has transformed bacterial functional genomics by creating saturated libraries of mutants and reading out insertion sites with deep sequencing, but adapting the technique to phages has been difficult because phages cannot be transformed with plasmids and their replication cycles are brief and tightly regulated.

The Otago team solved the selection problem with an elegant trick borrowed from the ongoing evolutionary arms race between bacteria and viruses. Their system couples Tn5 transposon mutagenesis to anti-CRISPR-based counter-selection. Phages are first propagated in host bacteria that express the Tn5 transposase together with a transposon carrying an anti-CRISPR gene, in this case AcrVIA1, which inhibits the RNA-targeting nuclease Cas13a. Only phage genomes that have acquired the transposon, and therefore the anti-CRISPR gene, can replicate in a second host strain that expresses Cas13a loaded with spacers targeting the phage. Unmutated phages are destroyed or blocked by the CRISPR defense, while transposon-bearing mutants are selectively enriched. Deep sequencing of the enriched population then reveals, across the whole genome, where insertions survived and where they were eliminated.

The logic of the readout is straightforward: genes that tolerate no transposon insertions after enrichment are essential for phage replication, whereas genes riddled with insertions are dispensable. Applying the method to phage JS26, a T7-like virus of the bacterium Prodigiosinella confusarubida, the researchers generated a genome-wide essentiality map that agreed well with independent lines of evidence, including structural proteomics of purified virions and conservation of core genes across related phages. Genes encoding capsid and tail components, DNA replication machinery, and other core functions showed the expected depletion of insertions, while genes of unknown or auxiliary function were heavily disrupted.

A particularly demanding test was the nucleus-forming jumbo phage PCH45, a relative of the well-studied phiKZ-like viruses of Pseudomonas. These giant phages, with genomes exceeding 200 kilobases, build a nucleus-like proteinaceous compartment inside the infected cell that shields their replicating DNA from CRISPR-Cas nucleases. The team found that standard transposase worked poorly in this context, so they engineered a fusion between the transposase and UvsX, a phage recombination protein that localizes to the viral nucleus. This UvsX-TnpA fusion dramatically improved mutagenesis of PCH45, allowing the researchers to construct the first genome-scale essentiality map for a nucleus-forming jumbo phage and to distinguish essential core genes from the large complement of non-essential genes that characterize these remarkable viruses.

Beyond essentiality, the method extracts information from the biases inherent in transposon insertion. Because Tn5 inserts preferentially into certain sequence contexts and strand orientations, the distribution of insertions carries signals about genome organization. The researchers showed that insertion orientation biases allowed them to predict the direction of transcription of phage genes, and that insertion density correlated with expression levels, enabling identification of regions injected early into the host and genes expressed at high levels during infection. The insertion index across non-essential genes showed a moderate positive correlation with RNA-seq expression measurements, demonstrating that a single mutagenesis experiment can yield both functional and regulatory information.

The transposon itself proved to be a versatile delivery vehicle. By modifying the cargo carried within the transposon, the team generated phages labeled with fluorescent proteins within a few days, a task that conventional phage engineering approaches can take weeks to accomplish. They also created an orthogonal system based on an artificial intelligence-designed anti-CRISPR protein, allowing a second, distinguishable transposon to be delivered into phages that already carried the first. Using this approach they constructed phage double mutants carrying two different transposons, each conferring resistance to a different Cas13a variant, which permitted sequential counter-selection. The strategy worked across several diverse phages, including LC53 and Bas46, infecting different bacterial hosts.

One further technical hurdle was DNA modification. Many phages protect their genomes from host defenses with heavily modified bases, such as hypermodified cytosines, which can block enzymatic steps in genome engineering. The researchers demonstrated that transposon insertion was achievable even in phages with such hypermodified DNA, extending the reach of the method to viruses whose chemical biology has historically resisted manipulation. This breadth matters because modified DNA is common among phages that are attractive candidates for therapeutic development, precisely because modifications help them evade bacterial immune systems.

The implications extend in two directions. For basic science, phage Tn-seq provides an unbiased, high-throughput entry point into the functional genomics of viruses whose genes are largely unannotated, complementing recent parallel efforts such as CRISPRi-based phage screens and other transposon approaches reported for bacteriophages. Essentiality maps anchored by proteomics and conservation data give researchers a rational basis for assigning functions to the growing torrent of phage genome sequences generated by environmental sequencing. For applied science, the ability to insert cargo rapidly and at many genomic positions addresses a persistent bottleneck in phage therapy engineering, where researchers seek to equip therapeutic phages with traits such as reporter genes, altered host ranges, or additional anti-defense functions without laborious homologous recombination protocols.

The authors have made the underlying resources broadly available. Raw sequencing data are deposited in the NCBI Sequence Read Archive under BioProject PRJNA1381746, proteomics datasets are accessible through the PRIDE repository, and the plasmids developed for the system, including the transposon delivery and selection constructs, are deposited at Addgene. As phage-based antimicrobials move closer to clinical and agricultural deployment amid rising antibiotic resistance, tools that compress the design-build-test cycle for viral genomes are likely to become standard equipment in the phage engineering toolbox. Phage Tn-seq, by simultaneously mapping what a phage cannot live without and delivering what engineers want to add, offers both the map and the vehicle in a single experiment.

Subject of Research: Genome-wide essentiality mapping and transposon-based engineering of bacteriophages

Article Title: Defining the essential genome of diverse phages with phage Tn-seq

Article References: Kyte, N., Fuchs, M., Smith, L. M., & Fineran, P. C. (2026). Defining the essential genome of diverse phages with phage Tn-seq. Nature Microbiology. https://doi.org/10.1038/s41564-026-02486-1

Image Credits: AI Generated

DOI: 10.1038/s41564-026-02486-1

Keywords: bacteriophage, phage Tn-seq, transposon mutagenesis, gene essentiality, anti-CRISPR, jumbo phage, phage engineering, functional genomics, phage therapy, Cas13a, DNA modification, biotechnology

The platform, named HOMEBRED for highly sensitive and specific omnipresent multiplex endonuclease-based reliable detection, is built on the SHERLOCK architecture that harnesses the CRISPR-associated protein Cas13a. When Cas13a finds the RNA sequence its guide molecule instructs it to find, it does not merely cut the target; it shreds any nearby RNA indiscriminately. This collateral cleavage activity is the engine of the assay. Synthetic RNA reporters carrying a fluorescent dye and a quencher float in the reaction; if the target is present, the reporters are cleaved, the fluorescence escapes, and the result can be read with the naked eye under an inexpensive handheld blue light or on paper-based lateral flow strips. No thermocycler, no sequencer, no fluorescence plate reader is required at any stage.

What separates HOMEBRED from earlier CRISPR diagnostics is the way its guide RNAs are chosen. Fragile crRNA target windows have been a chronic vulnerability in CRISPR-based tests, because a single mutation in the target sequence can silence the assay entirely, allowing an evolving pathogen to escape detection. The team addressed this with CaSilico, an automated computational pipeline that screens thousands of genome sequences to identify highly conserved, mutation-resistant regions. For foot-and-mouth disease virus, one of the most genetically variable livestock pathogens known, CaSilico analyzed 707 sequences of the conserved 3D gene across all seven serotypes, applying a 98 percent conservation threshold and yielding 41 candidate target sites from which two crRNAs were selected using stringent thermodynamic and specificity criteria.

That computational rigor proved consequential in practice. One of the two initial foot-and-mouth disease virus crRNAs, CR3D1, looked ideal on paper yet failed to detect the virus in the laboratory. When the researchers examined its predicted secondary structures in detail, they found that the centroid structure, not just the minimum free energy fold, deviated from the stable hairpin architecture that Cas13a requires for recognition. This failure mode has been observed by other groups, and the finding underscores a lesson increasingly clear in the field: guide RNA design must weigh thermodynamic structure predictions as carefully as sequence conservation. The redesigned guide, CR3D2, worked flawlessly, correctly classifying all 11 clinical samples in complete agreement with reference RT-qPCR, with detection limits reaching down to ten copies per microliter in both fluorescent and lateral flow formats.

Perhaps the most consequential demonstration involves brucellosis, a bacterial zoonosis that infects an estimated 300 million of the world’s 1.4 billion cattle and for which no human vaccine exists. Veterinary control programs face a stubborn problem known as DIVA, the inability to differentiate infected animals from vaccinated ones. A false positive in a vaccinated, high-breeding-value animal can trigger needless culling, while a missed infection lets the disease spread silently. HOMEBRED tackles this with a dual-crRNA architecture: one guide targets the conserved bcsp31 gene to detect the four major Brucella species, while a second exploits a deletion mutation in the narJ gene unique to the RB51 vaccine strain. In testing, the platform signaled every wild-type culture of B. melitensis, B. abortus and B. suis while remaining silent against the vaccine strain, achieving 100 percent concordance with reference PCR across all 14 samples tested.

The platform also ventures into oncology. BCR-ABL1 fusion transcripts, produced when chromosomes 9 and 22 break and rejoin, are the hallmark of chronic myeloid leukemia, and the specific transcript isoform a patient carries influences response to tyrosine kinase inhibitor therapy. HOMEBRED distinguished the e13a2, e14a2 and e1a2 isoforms using isoform-specific guide RNAs and recombinase polymerase amplification primers sharing a common reverse primer on the ABL1 gene. Validated against the KCL-22 and K-562 leukemia cell lines and 14 clinical samples, the assay matched Sanger sequencing in specificity and exceeded RT-qPCR in sensitivity. Strikingly, three samples that reference RT-qPCR had called negative were positive by HOMEBRED, and two patients were found to co-express two transcript types simultaneously, findings with direct implications for treatment selection and minimal residual disease monitoring.

Two reaction formats were compared head to head. The two-step assay runs amplification and detection in separate tubes, while the single-step format folds both into one pot, reducing handling time and contamination risk. For Brucella, the one-pot version matched the two-step version perfectly, but for foot-and-mouth disease virus it dropped to 77 percent agreement, missing three positives and losing roughly an order of magnitude in detection limit. The authors conclude that the two-step format remains the safer default when sensitivity is paramount, reserving the single-step format for targets where its performance is proven. All duplicate reactions across both formats achieved 100 percent qualitative concordance, 111 out of 111 pairs, a reproducibility figure that speaks to careful optimization.

The extraction-free capability is where HOMEBRED pushes furthest past the existing literature. Traditional purification, when skipped, usually devastates sensitivity because crude biological matrices carry enzymatic inhibitors such as hemin and polysaccharides. The team paired their assay with HUDSON, a method that heats samples with chemical reducers to destroy nucleases and release genetic material, and applied it directly to vesicular fluid and epithelial tissue from foot-and-mouth disease cases. Without any nucleic acid extraction, the workflow detected viral seedstock down to 3.23 times ten to the fourth plaque-forming units per milliliter by colorimetric readout and 3.23 times ten to the third by fluorescence, an improvement of up to two orders of magnitude over comparable extraction-free CRISPR assays. The strategic choice of epithelial tissue, which proves far more chemically compatible with the HUDSON reaction than blood or feces, appears central to this performance.

Robustness against real-world genetic drift was verified by sequencing. Sanger analysis of foot-and-mouth disease virus samples confirmed that the computationally designed target region stayed fully conserved across strains, with a single substitution in one sample that failed to impair detection. Two leukemia clinical samples harbored point mutations inside the protospacer region, and HOMEBRED still called both correctly with no signal loss. The choice of Cas13a over the Cas12a enzymes used in several rival platforms also matters here: Cas13a requires no protospacer adjacent motif, freeing guide design from target-site constraints that are particularly restrictive when isolating the narrow junctions of fusion transcripts, and its vigorous trans-cleavage activity sustains signal generation even at suboptimal temperatures.

The authors acknowledge limits. Clinical isolates of B. canis could not be physically tested due to regional availability, so the team verified the assay against synthetic DNA carrying the identical conserved bcsp31 target domain, supported by sequence alignments showing 100 percent identity. No accessible cell line expressing the minor e1a2 transcript was available for extended in vitro benchmarking. Future work, they write, should prioritize lyophilized reagent formulations to round out farm-level deployment. Even with those caveats, HOMEBRED demonstrates that a single CRISPR platform, guided by automated conserved-region design and read by nothing more sophisticated than a handheld blue light, can deliver sensitivity on par with PCR across livestock pathogens, zoonotic bacteria, respiratory viruses and leukemia biomarkers, a convergence that could materially narrow the diagnostic gap between well-resourced laboratories and the places where early detection matters most.

Subject of Research: A CRISPR-Cas13a diagnostic platform enabling instrument-free detection of infectious agents and oncogenic mutations

Article Title: HOMEBRED: A unified CRISPR platform for field-ready shadowing of infectious agents and oncogenic mutations

Article References: Asadbeigi, A., Fazilaty, H., Saffari, M., Shirkoohi, R., Modarressi, M. H., Salehi, A., & Bakhtiarizadeh, M. R. (2026). HOMEBRED: A unified CRISPR platform for field-ready shadowing of infectious agents and oncogenic mutations. iScience, 29(10), Article 117532. https://doi.org/10.1016/j.isci.2026.117532

Image Credits: AI Generated

DOI: 10.1016/j.isci.2026.117532

Keywords: CRISPR diagnostics, Cas13a, SHERLOCK, HOMEBRED, foot-and-mouth disease virus, brucellosis, SARS-CoV-2, BCR-ABL1, chronic myeloid leukemia, recombinase polymerase amplification, DIVA, point-of-care testing